Furthermore, the proliferation and apoptosis associated proteins were also determined by using the Western Blot analysis, and the results showed that high-dose doxorubicin combined with 3-MA significantly inhibited cyclin D1 and CDK2, and upregulated Bax in DR-BC cells (Fig. S2A-D). The gene discussed is CDK2; the disease is breast cancer.